Aurobindo Fair Value
AU
The fair market value of AUROPHARMA.NS stock is 801.25 INR. Relative to the market price of 1249.45 INR Aurobindo is overvalued by 35.9%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Aurobindo Valuation
Current AUROPHARMA.NS share ticker price is 1249.45 INR.
The fair value level of 801.25 INR can be considered as an effective entry point for long-term investors to start investing in AUROPHARMA.NS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 36% higher its fair value
Current price is 64% higher its minimum value
Current price is 6% higher its maximum value
Market price:
AUROPHARMA.NS stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Aurobindo Pharma Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
21.58
2
Median P/E over 5 years
14.77
3
Minimum P/E over 5 years
8.32
4
Earning per share (last 12 months)
54.23 INR
Maximum value
1
x
4
=
1 170.26 INR
Fair value
2
x
4
=
801.25 INR
Minimum value
3
x
4
=
451.46 INR
Aurobindo Pharma Ltd price metrics
24.89
Annual return (geometric mean)
38.9
Risk (standard deviation) of returns
β
0.72
Beta (volatility compared to market)